Signaling through PD-1 keeps activated T cells from killing tumor cells or infected target cells in the setting of persistent infection and cancers, and thus regulates the balance between T-cell activation, tolerance, and immunopathology [129]. This evidence concerns the gene PDCD1 and neoplasm.